Household & Personal Products

Colgate‑Palmolive insider sale: 2,300 shares sold by the senior controller—no impact on control, but a glimpse into exec liquidity strategies and SEC compliance.

Nevisense tech: Kenvue, Castle Biosciences eye 2026 trial & data release to boost skin‑barrier diagnostics for atopic dermatitis. Insights & market impact.

AI‑driven growth fuels 2026 results: 24‑28 % margin, disciplined costs, and new analytics services propel a resilient, shareholder‑friendly strategy.

Church & Dwight’s small phantom‑stock awards raise governance and alignment questions – explore how limited executive incentives affect shareholder value and corporate oversight.

Procter & Gamble names new CFO Ashween Anand, updates stock options, and deploys QIP funds for growth, supply‑chain resilience and shareholder value.

Unilever’s 2026 debt‑issuance strategy and audited finance reports reveal its regulatory‑smart capital play, while Magnum’s tax‑free spinoff sparks short‑term market buzz but limited PE interest.

Henkel’s 150‑year legacy fuels new sustainable hair‑care innovations like RE:TINT, blending clean beauty, digital diagnostics and eco‑friendly packaging to outpace rivals.

Director Price Penry W. flips Church & Dwight stock: buying at $50, selling at $95 in one day—insider strategy, governance hints, and future impact on shareholder value.

Discover how Kenvue blends bilingual hiring at Bogotá’s job fair with vigilant pharma‑market watch to stay competitive and grow globally.

Unilever raises its 2025 dividend by 3%, boosting the yield to 3.55% as the company signals confidence in long‑term growth, robust cash flow, and a resilient consumer‑goods strategy.